CLINICAL_TRIALS
trial_result
· 2013-11-21
Clinical Trial Update: Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212 [Phase 2]
Summary
Phase 2 clinical trial update on safety, pharmacokinetics, and pharmacodynamics for GSK2118436 and GSK1120212 completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-21